FR2215228A1 - - Google Patents

Info

Publication number
FR2215228A1
FR2215228A1 FR7402599A FR7402599A FR2215228A1 FR 2215228 A1 FR2215228 A1 FR 2215228A1 FR 7402599 A FR7402599 A FR 7402599A FR 7402599 A FR7402599 A FR 7402599A FR 2215228 A1 FR2215228 A1 FR 2215228A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7402599A
Other languages
French (fr)
Other versions
FR2215228B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of FR2215228A1 publication Critical patent/FR2215228A1/fr
Application granted granted Critical
Publication of FR2215228B1 publication Critical patent/FR2215228B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/18Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/24Derivatives of thiourea containing any of the groups, X being a hetero atom, Y being any atom
    • C07C335/26Y being a hydrogen or a carbon atom, e.g. benzoylthioureas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42Sulfonylthioureas; Sulfonylisothioureas

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7402599A 1973-01-26 1974-01-25 Expired FR2215228B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2303761A DE2303761A1 (de) 1973-01-26 1973-01-26 Neue n,n'-disubstituierte thioharnstoffe, deren herstellung sowie verwendung als antimikrobielle substanzen

Publications (2)

Publication Number Publication Date
FR2215228A1 true FR2215228A1 (enExample) 1974-08-23
FR2215228B1 FR2215228B1 (enExample) 1977-09-09

Family

ID=5870017

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7402599A Expired FR2215228B1 (enExample) 1973-01-26 1974-01-25

Country Status (7)

Country Link
US (1) US3966968A (enExample)
BE (1) BE810147A (enExample)
DE (1) DE2303761A1 (enExample)
FR (1) FR2215228B1 (enExample)
GB (1) GB1397234A (enExample)
IT (1) IT1053752B (enExample)
NL (1) NL7317791A (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ425698A3 (cs) * 1996-06-27 1999-06-16 Smithkline Beecham Corporation Antagonista IL-8 receptoru
US6133319A (en) * 1996-06-27 2000-10-17 Smithkline Beecham Corporation IL-8 receptor antagonists
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AR041834A1 (es) * 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
KR20050111306A (ko) 2002-11-19 2005-11-24 아칠리온 파르마세우티칼스 인코포레이티드 바이러스 복제 억제제로서의 치환된 아릴 티오우레아 및관련 화합물
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
EA014958B1 (ru) * 2006-04-21 2011-04-29 Смитклайн Бичам Корпорейшн Антагонисты рецептора il-8
JP2009534420A (ja) * 2006-04-21 2009-09-24 スミスクライン・ビーチャム・コーポレイション Il−8受容体アンタゴニスト
AR061571A1 (es) * 2006-06-23 2008-09-03 Smithkline Beecham Corp Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
DE102008047743A1 (de) * 2008-09-17 2010-04-15 Henkel Ag & Co. Kgaa Verwendung von Harnstoff-Derivaten und Phenacylthiazolium-Salzen zur Behandlung von Körpergeruch
US8028844B2 (en) * 2008-11-20 2011-10-04 Costa Charles A Sliding closet rack
US20110305751A1 (en) 2009-02-20 2011-12-15 To-Bbb Holding B.V. Glutathione-based drug delivery system
AU2010245823B2 (en) 2009-05-06 2016-11-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
DE102009029370A1 (de) 2009-09-11 2011-03-24 Henkel Ag & Co. Kgaa Inhibierung von Körpergerüchen
US8628961B2 (en) * 2010-05-18 2014-01-14 Tufts University Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2150833A1 (enExample) * 1971-08-23 1973-04-13 Medizinska Akad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193403A (enExample) * 1953-12-22 1924-02-17
US3686418A (en) * 1969-10-23 1972-08-22 Armour & Co N-acyl-n{40 -(halogenated aryl ureas as antibacterial agents)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2150833A1 (enExample) * 1971-08-23 1973-04-13 Medizinska Akad

Also Published As

Publication number Publication date
DE2303761A1 (de) 1974-08-01
FR2215228B1 (enExample) 1977-09-09
IT1053752B (it) 1981-10-10
BE810147A (fr) 1974-07-25
NL7317791A (enExample) 1974-07-30
GB1397234A (en) 1975-06-11
US3966968A (en) 1976-06-29

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
AU474511B2 (enExample)
AU474838B2 (enExample)
FR2215228B1 (enExample)
AU471343B2 (enExample)
AU465453B2 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU466283B2 (enExample)
AR199451A1 (enExample)
AU476696B2 (enExample)
AU472848B2 (enExample)
AU477823B2 (enExample)
AR197627A1 (enExample)
AR195948A1 (enExample)
AR200256A1 (enExample)
AU477824B2 (enExample)
AR200885A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse